Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Notable Analyst Rating Changes 05/14: (WY) (FIO) (MDRX) Upgraded; (CI) (KBH) (AVG) Downgraded
-
StreetInsider.com Pre-Open Movers 12/20: (NYX) (RAD) (ILMN) Higher; (FOLD) (MDRX) (SYMM) Lower (more...)
-
Notable Analyst Rating Changes 11/09: (ISIS) (FAST) (MRO) Upgraded; (PSX) (MDRX) (CSCO) Downgraded
-
Notable Analyst Rating Changes 04/27: (SNDK) (ZNGA) (AMZN) Upgraded; (MDRX) (STX) (DECK) Downgraded
-
Deutsche Bank Reiterates a 'Buy' on Allscripts-Misys Healthcare (MDRX); Bookings Highlight 3Q, Focus Shifts 'Down Under' for 4Q
-
Notable Analyst Rating Changes 04/07: (HERO) (ELN) (CRM) Upgraded; (MDRX) (CNL) (SSW) Downgraded
-
Deutsche Bank Reiterates a 'Buy' on Allscripts-Misys Healthcare (MDRX); 'Crosses' Into FY11 on Strong Footing
-
Notable Analyst Rating Changes 01/27: NFLX, TRW, QCOM, SYMC Upgraded; GT, MUR, GNK, ABT Downgraded
-
Deutsche Bank Upgrades Allscripts-Misys Healthcare (MDRX) to Buy
-
Notable Analyst Rating Changes 09/02: HPQ, RTP, MPEL, ZUMZ Upgraded; PPL, VALE, CRH, AMPH Downgraded
-
Deutsche Bank Reinstates Allscripts (MDRX) with a 'Hold'; ECLP Transaction May Yield Upside, But Valuation & Risks Balanced
-
Deutsche Bank Upgrades Allscripts-Misys (MDRX) to Hold; Fair Risk/Reward Profile
-
Morning Movers 2/24: Rambus (RMBS) Jumps On Ruling; MAP Pharma (MAPP) Slammed On Drug Results
-
Deutsche Bank Downgrades Allscripts-Misys (MDRX) to Sell
-
Notable Analyst Rating Changes 6/6: PNRA, BTU, CSC Upgraded; BBY, BRP, MVL Downgraded
-
Deutsche Bank Downgrades Allscripts (MDRX) to Hold; Cuts PT to $15.50
